Hesperidin methyl chalcone alleviates imiquimod-induced psoriasis.
Hesperidin methyl chalcone alleviates imiquimod-induced psoriasis in mice: effects alone and in combination with methotrexate.
AI Summary
Key Findings
Abstract
Psoriasis is a common chronic inflammatory skin disease with an increasing worldwide prevalence. Hesperidin methyl chalcone (HMC), a water-soluble derivative of the flavonoid "hesperidin", exhibits antioxidant and anti-inflammatory effects. However, its effects on psoriasis have never been investigated. Therefore, this study aims to evaluate the ameliorative effects of HMC, alone and in combination with methotrexate (MTX) in an imiquimod (IMQ)-induced psoriasis mice model. Twenty-five adult female BALB/c mice were randomized into five groups. Except for the control group, all mice received topical IMQ cream (62.5 mg of 5%) for six consecutive days; controls received Vaseline instead as a vehicle. Treated groups were orally administered MTX (1 mg/kg body weight "b.wt"), HMC (500 mg/kg b.wt), or their combination once daily. Our data revealed that HMC alone markedly attenuated skin erythema, scaling, epidermal hyperplasia, body weight loss, and histopathological alterations, while significantly (P
Affiliation
Hagar W Abdelrahman
External References
- PubMed ID:
- 41387647
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.